Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

Ironwood Pharmaceuticals (Nasdaq: IRWD), a leading gastrointestinal healthcare company, announced management presentations at two key investor conferences. The events include the Cowen 42nd Annual Health Care Conference on March 9, 2022, at 10:30 a.m. ET, and the Barclays Global Healthcare Conference on March 15, 2022, at 3:20 p.m. ET. Live webcasts of these presentations will be available on Ironwood's website, with replays accessible for 14 days after the conferences. Ironwood is dedicated to advancing treatment for GI diseases, notably with its leading product LINZESS®.

BOSTON--(BUSINESS WIRE)--

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that management will be presenting at the following investor conferences:

• Cowen 42nd Annual Health Care Conference on Wednesday, March 9, 2022 at 10:30 a.m. ET
• Barclays Global Healthcare Conference on Tuesday, March 15, 2022 at 3:20 p.m. ET

A live webcast of Ironwood’s presentations will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcasts, please log on to the Ironwood website approximately 15 minutes prior to the start times to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Ironwood’s website for 14 days following the conferences.

About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Under the guidance of our seasoned industry leaders, we continue to build upon our history of GI innovation and challenge what has been done before to shape what the future holds. We keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.

Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts.

We routinely post information that may be important to investors on our website at www.ironwoodpharma.com. In addition, follow us on Twitter and on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220302005153/en/

Investors:

Matt Roache, 617-621-8395

Director, Investor Relations

mroache@ironwoodpharma.com

Source: Ironwood Pharmaceuticals, Inc.

FAQ

When will Ironwood Pharmaceuticals present at the Cowen 42nd Annual Health Care Conference?

Ironwood Pharmaceuticals will present at the Cowen 42nd Annual Health Care Conference on March 9, 2022, at 10:30 a.m. ET.

What is the date and time for Ironwood's presentation at the Barclays Global Healthcare Conference?

Ironwood Pharmaceuticals will present at the Barclays Global Healthcare Conference on March 15, 2022, at 3:20 p.m. ET.

How can I access the webcasts of Ironwood Pharmaceuticals' presentations?

The live webcasts of Ironwood Pharmaceuticals' presentations can be accessed through the Investors section of their website.

How long will the webcasts of Ironwood Pharmaceuticals' investor presentations be available for replay?

The replays of Ironwood Pharmaceuticals' webcasts will be available for 14 days following the conferences.

What is Ironwood Pharmaceuticals known for?

Ironwood Pharmaceuticals is known for its focus on gastrointestinal healthcare and the development of LINZESS®, a leading treatment for GI diseases.